Cargando…

The significance of routine biochemical markers in patients with major depressive disorder

The aim of our study is to examine the levels of routine biochemical markers in patients with major depressive disorder (MDD), and combine multiple biochemical parameters to assess the discriminative power for patients with MDD. We used the Hamilton Depression (HAMD) score to evaluate the severity o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, You-Fan, Xiang, Yang, Wei, Ye-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041142/ https://www.ncbi.nlm.nih.gov/pubmed/27683078 http://dx.doi.org/10.1038/srep34402

Ejemplares similares

Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder
por: Zhu, Yuncheng, et al.
Publicado: (2022)

Blood Transcriptomic Markers in Patients with Late-Onset Major Depressive Disorder
por: Miyata, Shigeo, et al.
Publicado: (2016)

Biochemical and Sociodemographic Correlates of Major Depressive Disorder in Patients With Chronic Kidney Disease Receiving Hemodialysis
por: Kumar, Ashutosh, et al.
Publicado: (2023)

Altered network efficiency in major depressive disorder
por: Ye, Ming, et al.
Publicado: (2016)

Evaluation of major depression in a routine clinical assessment
por: Mezzasalma, Marco André Urbach
Publicado: (2010)

Longitudinal Estimation of the Clinically Significant Change in the Treatment of Major Depression Disorder
por: Cañete-Massé, Cristina, et al.
Publicado: (2018)

MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder
por: Stapel, Britta, et al.
Publicado: (2022)

Differences and correlations of biochemical index levels in patients with bipolar disorder and major depressive disorder during a stable period
por: Tan, Yukang, et al.
Publicado: (2023)

Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice
por: Lee, Kyung Ho, et al.
Publicado: (2020)

On the Significance of New Biochemical Markers for the Diagnosis of Premature Labour
por: Rzepka, Rafał, et al.
Publicado: (2014)

Clinical Significance of the Number of Depressive Symptoms in Major Depressive Disorder: Results from the CRESCEND Study
por: Park, Seon-Cheol, et al.
Publicado: (2016)

Biochemical markers of depression - an up-to-date review
por: Nobis, A., et al.
Publicado: (2021)

Identification of Diagnostic Markers for Major Depressive Disorder Using Machine Learning Methods
por: Zhao, Shu, et al.
Publicado: (2021)

Cross-sectional field study comparing hippocampal subfields in patients with post-traumatic stress disorder, major depressive disorder, post-traumatic stress disorder with comorbid major depressive disorder, and adjustment disorder using routine clinical data
por: Knaust, Thiemo, et al.
Publicado: (2023)

Usefulness of the Spanish version of the mood disorder questionnaire for screening bipolar disorder in routine clinical practice in outpatients with major depression
por: de Dios, Consuelo, et al.
Publicado: (2008)

The serum zinc concentration as a potential biological marker in patients with major depressive disorder
por: Styczeń, Krzysztof, et al.
Publicado: (2016)

Elevated levels of glutathionyl haemoglobin as an oxidative stress marker in patients with major depressive disorder
por: Mathew, Boby, et al.
Publicado: (2019)

Comparative analysis of plasma metabolomics markers in patients with major depressive disorder and healthy controls
por: Homorogan, C., et al.
Publicado: (2022)

Plasma complement component 4 increases in patients with major depressive disorder
por: Wei, Jinxue, et al.
Publicado: (2017)

Sex differences in gut microbiota in patients with major depressive disorder
por: Chen, Jian-jun, et al.
Publicado: (2018)

Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA)
por: Ramsey, Jordan M., et al.
Publicado: (2016)

Impaired social decision making in patients with major depressive disorder
por: Wang, Yun, et al.
Publicado: (2014)

Assessment of biochemical bone markers of osteoporosis in children with thalassemia major
por: Çelik, Tanju, et al.
Publicado: (2022)

High level of pattern glare in major depressive disorder
por: Qi, Xiongwei, et al.
Publicado: (2019)

The effectiveness of mindfulness-based cognitive therapy for major depressive disorder: evidence from routine outcome monitoring data
por: Geurts, Dirk E.M., et al.
Publicado: (2020)

Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder
por: Doruk Camsari, Deniz, et al.
Publicado: (2019)

Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder
por: Green, Claire, et al.
Publicado: (2021)

Vortioxetine Modulates the Regional Signal in First-Episode Drug-Free Major Depressive Disorder at Rest
por: Xiong, Shihong, et al.
Publicado: (2022)

Do patients’ resilience and subjective illness representation predict the outcome of a routine inpatient treatment program of major depressive disorder?
por: Marschollek, Laura, et al.
Publicado: (2021)

Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder
por: Tadić, André, et al.
Publicado: (2011)

Risk Factors for Anxiety in Major Depressive Disorder Patients
por: Xin, Li-Min, et al.
Publicado: (2015)

Gene × environment interaction in major depressive disorder
por: Zhao, Ming-Zhe, et al.
Publicado: (2021)

Sex differences in the clinical characteristics and brain gray matter volume alterations in unmedicated patients with major depressive disorder
por: Yang, Xiao, et al.
Publicado: (2017)

Biochemical Markers for Prediction of Hypertensive Disorders of Pregnancy
por: Belovic, Dušica Kocijančić, et al.
Publicado: (2019)

Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
por: Almeida, Susana S, et al.
Publicado: (2022)

Heart Rate Variability Biofeedback Increased Autonomic Activation and Improved Symptoms of Depression and Insomnia among Patients with Major Depression Disorder
por: Lin, I-Mei, et al.
Publicado: (2019)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
por: Yang, Xiao, et al.
Publicado: (2015)

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
por: Kern, David M., et al.
Publicado: (2023)

Age-specific urinary metabolite signatures and functions in patients with major depressive disorder
por: Chen, Jian-Jun, et al.
Publicado: (2019)

Predictors of recurrence of major depressive disorder
por: Lye, Munn-Sann, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e0a9ma2bodvsnbbkl2glld7als